Diaceutics PLC (DXRX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.021x

Based on the latest financial reports, Diaceutics PLC (DXRX) has a cash flow conversion efficiency ratio of 0.021x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX800.00K ≈ $97.34 USD) by net assets (GBX37.24 Million ≈ $4.53K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Diaceutics PLC defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Diaceutics PLC - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Diaceutics PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Diaceutics PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Diaceutics PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Quartix Holdings Plc LSE:QTX	0.121x
KARELIAN DIA.R. EO-00025 F:KJY1	N/A
Borders & Southern Petroleum plc LSE:BOR	-0.003x
SRx Health Solutions Inc. NYSE MKT:SRXH	18.676x
Sienna Resources Inc V:SIE	-0.071x
Gossan Resources Ltd V:GSS	-0.099x
Conduit Capital Ltd JSE:CND	-0.290x
Solid Clouds hf IC:SOLID	N/A

Annual Cash Flow Conversion Efficiency for Diaceutics PLC (2016–2024)

The table below shows the annual cash flow conversion efficiency of Diaceutics PLC from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see DXRX market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX39.86 Million ≈ $4.85K	GBX651.00K ≈ $79.21	0.016x	-49.19%
2023-12-31	GBX40.79 Million ≈ $4.96K	GBX1.31 Million ≈ $159.51	0.032x	-73.18%
2022-12-31	GBX42.51 Million ≈ $5.17K	GBX5.10 Million ≈ $620.04	0.120x	+754.82%
2021-12-31	GBX40.65 Million ≈ $4.95K	GBX570.00K ≈ $69.35	0.014x	+123.02%
2020-12-31	GBX40.24 Million ≈ $4.90K	GBX253.00K ≈ $30.78	0.006x	+120.19%
2019-12-31	GBX20.13 Million ≈ $2.45K	GBX-627.05K ≈ $-76.29	-0.031x	+91.42%
2018-12-31	GBX2.63 Million ≈ $319.93	GBX-954.04K ≈ $-116.08	-0.363x	-144.41%
2017-12-31	GBX1.88 Million ≈ $228.47	GBX1.53 Million ≈ $186.66	0.817x	+22.70%
2016-12-31	GBX1.01 Million ≈ $123.16	GBX674.01K ≈ $82.01	0.666x	--

About Diaceutics PLC

LSE:DXRX UK Health Information Services

Market Cap

$1.47 Million

GBX12.06 Billion GBX

Market Cap Rank

#30235 Global

#746 in UK

Share Price

GBX142.50

Change (1 day)

+0.00%

52-Week Range

GBX113.00 - GBX176.50

All Time High

GBX187.50